<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04490668</url>
  </required_header>
  <id_info>
    <org_study_id>RJ-GC-Postop-complication 3</org_study_id>
    <nct_id>NCT04490668</nct_id>
  </id_info>
  <brief_title>Human Albumin and Anastomotic Leakage After Gastric Cancer Surgery</brief_title>
  <official_title>Association of Human Albumin With Anastomotic Leakage After Gastric Cancer Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruijin Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ruijin Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We investigate whether the intravenously administered human albumin is beneficial to prevent&#xD;
      anastomotic leakage after gastric cancer surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Anastomotic leakage after gastric cancer surgery is not very common but it is a very critical&#xD;
      postoperative complication. Anastomotic leakage severely compromises the recovery after&#xD;
      surgery. It increases the overall burden of patients and hospital resources. Postoperative&#xD;
      mortality is higher in patients with anastomotic leakage.&#xD;
&#xD;
      Human albumin is routinely administered after surgery with a unproven hypothesis that the&#xD;
      human albumin is beneficial to prevent anastomotic leakage. We investigate whether the&#xD;
      intravenously administered human albumin is beneficial to prevent anastomotic leakage after&#xD;
      gastric cancer surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">December 30, 2019</completion_date>
  <primary_completion_date type="Actual">July 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the rate of anastomotic leakage</measure>
    <time_frame>Up to one months after the discharge of last patient</time_frame>
    <description>The rate of anastomotic leakage were compared among both groups</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1049</enrollment>
  <condition>Gastric Cancer</condition>
  <condition>Anastomotic Leak</condition>
  <arm_group>
    <arm_group_label>Human albumin support</arm_group_label>
    <description>Patients who received intravenous human albumin after gastric cancer surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No human albumin support</arm_group_label>
    <description>Patients who did not receive intravenous human albumin after gastric cancer surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Human albumin</intervention_name>
    <description>Patients received intravenous human albumin after gastric cancer surgery. Overall quantity of human albumin were recorded.</description>
    <arm_group_label>Human albumin support</arm_group_label>
    <arm_group_label>No human albumin support</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with gastric cancer who underwent gastrectomy with adequate lymph node dissection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Histologically confirmed gastric cancer&#xD;
&#xD;
          -  Patients who underwent radical gastrectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient who did not undergo gastrectomy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birendra K Sah, PH D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ruijin Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chen Li, PH D</last_name>
    <role>Study Director</role>
    <affiliation>Ruijin Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhenggang Zhu, PH D</last_name>
    <role>Study Chair</role>
    <affiliation>Ruijin Hospital</affiliation>
  </overall_official>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 26, 2020</study_first_submitted>
  <study_first_submitted_qc>July 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2020</study_first_posted>
  <last_update_submitted>July 26, 2020</last_update_submitted>
  <last_update_submitted_qc>July 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ruijin Hospital</investigator_affiliation>
    <investigator_full_name>BIRENDRA KUMAR SAH</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Gastric Cancer</keyword>
  <keyword>Anastomotic leakage</keyword>
  <keyword>Human albumin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Anastomotic Leak</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

